Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Blood
|
November 16, 2002
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens
George Z Rassidakis, L Jeffrey Medeiros, Theodoros P Vassilakopoulos, et al.
Hematological Oncology
|
July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Vaccine
|
November 18, 2021
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age
Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Niranjan Bhat, et al.
The Lancet. Infectious Diseases
|
September 30, 2018
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial
Punnee Pitisuttithum, Kulkanya Chokephaibulkit, Chukiat Sirivichayakul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 28, 2017
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study
Colette Zwarthoed, Tarec Cristoffer El-Galaly, Maria Canepari, et al.
Cancer Medicine
|
July 26, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
Marc P E André, Patrice Carde, Simonetta Viviani, et al.
Clinical and Vaccine Immunology : CVI
|
July 15, 2011
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers
Helen Findlow, Samba Sow, Ray Borrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome
George Z Rassidakis, L Jeffrey Medeiros, Simonetta Viviani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Blood
|
April 14, 2018
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Enrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Blood
|
November 16, 2002
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens
George Z Rassidakis, L Jeffrey Medeiros, Theodoros P Vassilakopoulos, et al.
Hematological Oncology
|
July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Vaccine
|
November 18, 2021
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age
Kulkanya Chokephaibulkit, Thanyawee Puthanakit, Niranjan Bhat, et al.
The Lancet. Infectious Diseases
|
September 30, 2018
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial
Punnee Pitisuttithum, Kulkanya Chokephaibulkit, Chukiat Sirivichayakul, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 28, 2017
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study
Colette Zwarthoed, Tarec Cristoffer El-Galaly, Maria Canepari, et al.
Cancer Medicine
|
July 26, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
Marc P E André, Patrice Carde, Simonetta Viviani, et al.
Clinical and Vaccine Immunology : CVI
|
July 15, 2011
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers
Helen Findlow, Samba Sow, Ray Borrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome
George Z Rassidakis, L Jeffrey Medeiros, Simonetta Viviani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Blood
|
April 14, 2018
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Enrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Page
of 12